The Physician Payments Sunshine Act: The Insights Industry Position - Articles

Articles

28Oct

The Physician Payments Sunshine Act: The Insights Industry Position

On August 1, 2013, the first reporting period under the Physician Payment Sunshine Act began. Part of the Patient Protection and Affordable Care Act (aka, “Obamacare”), it requires pharmaceutical and medical device manufacturers to publicly report many types of payments made to physicians, which will be public. The Sunshine Act was intended to bring transparency to these relationships, to minimize manufacturers’ influence on physicians’ prescribing behavior.

Excluded: Payments to physicians for participating in survey, opinion and marketing research

Because payments to physicians for participating in pharmaceutical and medical device marketing research are typically made by research companies rather than manufacturer-sponsors, and to physicians whose identities are unknown to the manufacturer-sponsors, those payments are excluded from reporting under the Sunshine Act lawSEC. 1128G (e)(10)(A)The term ‘payment or other transfer of value’ means a transfer of anything of value. Such term does not include a transfer of anything of value that is made indirectly to a covered recipient through a third party in connection with an activity or service in the case where the applicable manufacturer is unaware of the identity of the covered recipient.

The Centers for Medicare and Medicaid Services (CMS) issued final rules implementing the Sunshine Act and reiterated this exclusion: 42 CFR § 403.904(i)(1)Indirect payments or other transfers of value… where the applicable manufacturer is unaware of the identity of the covered recipient. An applicable manufacturer is unaware of the identity of a covered recipient if the applicable manufacturer does not know… the identity of the covered recipient during the reporting year or by the end of the second quarter of the following reporting year.

Confusion: Single blind vs. double blind research

CMS explained the impact of the rules on marketing research: “For example, an applicable manufacturer may hire a market research firm to conduct a double-blinded market research study, which includes paying physicians $50 for responding to a set of questions.  The applicable manufacturer clearly intends a portion of the payment to be provided to physicians, but given that the reason for the third party's involvement is specifically to maintain the anonymity of the respondents and sponsor, we do not intend this to be considered a reportable indirect payment or other transfer of value.

Unfortunately, CMS created uncertainty for manufacturers by referencing in the example “a double-blinded market research study,” prompting some to wonder if single-blind research incentives are likewise excluded from reporting. The law, the regulations and the legislative history are clear: the focus of the Sunshine Act is on manufacturers’ knowing about the physician recipients of payments, not vice versa.

The Insights Association’s position on the Sunshine Act

  1. The letter and intent of the Sunshine Act exclude marketing research payments from public reporting requirements so long as research’s routine policies and conventions are followed – i.e., physician respondents are paid by the research firm and their identities remain unknown to manufacturer-sponsors.
  2. Carefully designed studies avoid any possibility that manufacturer-sponsors could inadvertently become aware of the identities of physicians participating in research and receiving respondent incentives.
  3. The identities of physician research participants should not be disclosed to manufacturer-sponsors without the participants' express consent regarding their disclosure and use.

This information is not intended and should not be construed as or substituted for legal advice. It is provided for informational purposes only. It is advisable to consult with private counsel on the precise scope and interpretation of any laws/regulation/legislation and their impact on your business.

(See a PDF of this 1-pager.)

About the Author

Howard Fienberg

Howard Fienberg

Based in Washington, DC, Howard is the Insights Association's lobbyist for the marketing research and data analytics industry, focusing primarily on consumer privacy and data security, the Telephone Consumer Protection Act (TCPA), tort reform, and the funding and integrity of the decennial Census and the American Community Survey (ACS). Howard has more than two decades of public policy experience. Before the Insights Association, he worked in Congress as senior legislative staffer for then-Representatives Christopher Cox (CA-48) and Cliff Stearns (FL-06). He also served more than four years with a science policy think tank, working to improve the understanding of scientific and social research and methodology among journalists and policymakers. Howard is also co-director of The Census Project, a 900+ member coalition in support of a fair and accurate Census and ACS. He has also served previously on the Board of Directors for the National Institute for Lobbying and Ethics and and the Association of Government Relations Professionals. Howard has an MA International Relations from the University of Essex in England and a BA Honors Political Studies from Trent University in Canada, and has obtained the Certified Association Executive (CAE), Professional Lobbying Certificate (PLC) and the Public Policy Certificate (PPC). When not running advocacy for the Insights Association, Howard enjoys hockey, NFL football, sci-fi and horror movies, playing with his dog, and spending time with family and friends.

Related

Issues of Interest to Insights Industry Surface in President Biden’s 2024 State of the Union Address

Issues of Interest to Insights Industry Surface in President Biden’s 2024 State of the Union Address

President Joe Biden’s recent State of the Union Address to Congress touched on a few policy areas o...

Read More >
Fighting for You: February 2024 Legislative and Regulatory Update

Fighting for You: February 2024 Legislative and Regulatory Update

This month, the Insights Association focused on extensive artificial intelligence legislation at the...

Read More >
Washington Health Data Privacy Law Coming into Effect March 31, 2024

Washington Health Data Privacy Law Coming into Effect March 31, 2024

The insights industry is running out of time to comply with the Washington My Health My Data Act, a ...

Read More >
Washington H.B. 1951 Could Restrict AI Use in Dealing with Research Subjects

Washington H.B. 1951 Could Restrict AI Use in Dealing with Research Subjects

Washington H.B. 1951 would regulate artificial intelligence (AI) used in decision-making, including ...

Read More >
Fighting for You: December 2023 Legislative and Regulatory Update

Fighting for You: December 2023 Legislative and Regulatory Update

As the insights industry closes out 2023 on the calendar, the Insights Association looked back at ou...

Read More >
Unemployment Insurance Modernization and Recession Readiness Act - S. 3140 and H.R. 6071

Unemployment Insurance Modernization and Recession Readiness Act - S. 3140 and H.R. 6071

The Unemployment Insurance Modernization and Recession Readiness Act (S. 3140, H.R. 6071) would like...

Read More >
Members only Article - Please login to view